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Thepurposeofthepresentstudywastoevaluatetherelativerisk(RR)ofmultiplebirthsforbirthdefectsafterassistedreproductive
technology(ART)usingJapanesenationwidedatafrom2004to2008withsingletonsasthereferencegroup.Inmultiplescompared
to singletons, the percentage of birth defects per pregnancy were signiﬁcantly higher (RR=1.88, 95% conﬁdence interval (CI)
1.60–2.13), the percentage of birth defects per live birth was not signiﬁcantly higher (RR=0.90, 95% CI0.78–1.05 or RR=0.94,
95% CI0.81–1.10), and the early neonatal mortality rate was signiﬁcantly higher (RR=2.68, 95% CI1.52–4.70 or RR=2.80, 95%
CI1.60–4.92). The early neonatal mortality per 10,000 live births was slightly higher in ART (5.09) than in the general population
(3.86). We concluded that the impact of birth defects after ART would be larger in families with multiples compared to families
with singletons, since the mean number of children would be larger in the former.
1.Introduction
The possibility of an association between assisted repro-
ductive technology (ART) and birth defects was raised as
early as 1987 [1]. In more recent years, as the number of
children born after ART increases, larger studies with more
robustmethodologieshavesuggestedthatchildrenbornafter
ART have an increased risk of birth defects compared with
children conceived spontaneously [2, 3].
Data from recent meta-analyses consistently suggest that
the overall risk of major birth defects in children born
after ART is about 30% higher than in children conceived
spontaneously [4, 5]. A more recent nationwide survey in
Sweden also showed a slightly increased risk for birth defects
after in vitro fertilization (IVF), even adjusting for possible
confounding factors, such as year of birth, maternal age, and
parity [6]. On the other hand, the ﬁrst large-scale report
of birth defects in 15,405 oﬀspring conceived by ART in
China found that infants born after IVF/ICSI have a birth
defect frequency comparable to that in the general Chinese
population [7].
Manystudiesandmeta-analyseshaveshownanincreased
risk for singletons conceived by ART [8, 9]. It is controversial
whether there is a risk to twins born after ART [9–11], in
part because of the fact that ART usually produces dizygotic
twins. It is well known that the medical outcome of dizy-
gotic twins is better than that of monozygotic twins [12].
Accordingtothemeta-analysisbyMcDonaldetal.[13],there
were no signiﬁcant diﬀerences in the number of birth defects
between spontaneous and IVF twins. A recent systematic
review comparing the data between spontaneous and ART
twin pregnancies/neonates showed that the birth defect rate
was equal in 7 of 9 studies [11].
It has been established that the prevalence of birth
defects is higher in multiples than in singletons in total
(not stratiﬁed by the method of conception), as shown in
national studies [14, 15] and an international study [16].
As is well known, multiple births occur far more often in
ART than spontaneous conception in almost all developed
countries [17–24] .T h em u l t i p l e - b i r t hr a t e( p e r1 , 0 0 0l i v e
births) increased twice during the past two decades, mainly
due to the increase of iatrogenic multiples, including ART
in Japan [24]. Therefore, the eﬀect of multiple births should
be considered when estimating the eﬀect of ART on birth
defects.
According to the Japanese ART and vital statistics,
which cannot be directly linked, the percentage of ART
live births were 1.64% (18,168/1,110,721) in 2004 and
1.99% (21,704/1,091,156) in 2008. Thus, the use of ART
is becoming widespread in Japan, but there are very few2 Journal of Pregnancy
epidemiologic reports on ART. One reason is because the
collection of the data on ART and birth defects in Japan is
notsystematicallymanagedbythegovernmentbutbyseveral
academic societies and it is very diﬃcult for researchers to
access personal information. The largest database on ART is
managed by the Japan Society of Obstetrics and Gynecology
(JSOG),asmentionedindetailinSection 2.Thelargestbirth
defects data is managed by the International Clearinghouse
for Births Defects Monitoring Systems (ICBDMS) Japan
Center, which is a volunteer hospital-based registry covering
about 10% of all births in Japan. However, this database does
not have detailed information on ART. Vital statistics (birth
records) from the Ministry of Health, Labour and Welfare of
Japan also list the number of birth defects in neonatal/infant
mortality but with no information on ART. These three
possibledatasourcesaremanagedindependently,andrecord
linkage is virtually impossible. With these essential limita-
tionsonthedatacollection,thepresentstudywasperformed.
Considering the increasing use of ART, the eﬀect of
multiple pregnancies in ART should be properly estimated.
The purpose of the present study was to oﬀer an overview of
birth defects after ART in Japan and to evaluate the relative
risk (RR) of multiple births, with singletons for reference, on
birth defects using Japanese nation-wide data.
2. Methods
2.1. Outline of Japanese ART and Birth Defects Data
2.1.1. ART Data. ART began in 1983 in Japan. Almost all
medical institutions performing ART are registered with the
JSOG. The JSOG administers questionnaire surveys for these
medical institutions. Some of the survey data are presented
in simple annual reports of aggregate, not individual, data
(with no information available in English). The JSOG has
gathered ART data from registered institutions since 1985.
The data items were not necessarily constant throughout the
surveillance period.
From 2004 to 2008 (the latest), the individual list of
all ART pregnancies having birth defects was presented
every year in the above-mentioned ART annual reports. The
presented items are method of treatment (IVF, microin-
semination (ICSI), frozen embryo transfer and others (du-
plicative methods), and do not include simple ovulation
stimulation/enhancement), maternal age, perinatal outcome
(spontaneous/artiﬁcial abortion (<22 weeks), stillbirths
(≤22 weeks), and live births) and their gestational week,
plurality (singleton, twins, triplets/+, and unknown), sex
(male, female, unknown), early neonatal infant death up
to day 6 (yes, no, unknown), and name of disease of birth
defects, including chromosomal abnormality (with no clear
deﬁnition or inclusion criteria for the birth defects).
The author used these data as initial information for
the present analyses. All methods of fertility treatment were
treated as ART in the present study, because the classiﬁcation
of these methods is not necessarily consistent and mutually
exclusive.
The response rate for ART surveillance between 2004
and 2008 was 97.7–99.5%, and the mean response rate
throughout the 5 years was 98.9%. In total 1,167 abortion,
stillbirths or live births with birth defects, consisting of 934
(80.0%) singletons, 218 (18.7%) twins, 11 triplets (0.9%),
and 4 (0.3%) unknown, were reported. Twins and triplets
weretreatedinonecategoryasmultiplesinthepresentstudy,
since the total number of ART live/stillbirths according to
subtype of multiples were not obtained.
2.1.2. Estimation of the Numbers of ART Singletons and
Multiples. The number of pregnancies, that is, the number
of total women with gestational sac, after ART was presented
according to plurality in the ART data. As for the ART births
(including both stillbirths and live births) data, the total
number of live deliveries and stillbirth deliveries, that is, the
number of total mothers, and live-births, that is, the number
of total neonates, were the only available data from 1989
to 2008. The numbers of multiple live-births according to
subtype were presented only in the 2007 and 2008 surveys.
For the multiple pregnancies, the mothers who had at least
one live-birth neonate were counted as a live delivery and
the others as stillbirth deliveries. For the multiple births,
the births were counted as live only when all neonates were
born alive. With these data limitations, the author estimated
the minimum and maximum numbers of ART singletons
and multiples between 2004 and 2006 using approximation
formulae [25].
2.2. Statistic Analyses. First, demographic and perinatal
outcome data of the subjects were calculated. For the
comparison between singletons and multiples, the t-test
was performed for maternal age and gestational weeks and
the χ2 test for birth year, sex, and perinatal outcome. The
signiﬁcance level was set at .05.
Next, the crude percentage of birth defects per ART
pregnancies and ART live-births were calculated according
to plurality and their RR with the corresponding 95%
conﬁdence interval (CI). The crude percentage of ART early
neonatal deaths with birth defects in live-births according
to plurality and their RR with the corresponding 95% CI
were also calculated. The crude percentage of birth defects
per total ART births, including both stillbirths and live-
births, were calculated, since the total ART births according
to plurality were not obtained. The comparison between
ART and the general population (vital statistics) concerning
the crude early neonatal mortality (within 7 days after birth)
rate related to birth defects (per 10,000 live-births) was
performed.
Stepwise multiple logistic regression analyses were per-
formed to determine which factors inﬂuence the neonatal
outcome of birth defects (stillbirths versus live-births, and
if live-births, whether early neonatal death occurred or not),
with a threshold signiﬁcance level of .05. The variables used
were birth year, plurality, maternal age, sex, and gestational
week. All statistical analyses were performed using SAS for
Windows ver. 9.2.
3. Results
Demographic and perinatal outcome data of ART preg-
nancies with birth defects are summarized according toJournal of Pregnancy 3
Table 1: Demographic and perinatal outcome data of the ART pregnancies with birth defects of known plurality.
Singletons (n = 934) Multiples (n = 229) P
n % n %
Birth year
2004 88 71.5a 35 28.5 a
<0.001
2005 119 77.3 35 22.7
2006 165 76.0 52 24.0
2007 240 79.5 62 20.5
2008 322 87.7 45 12.3
Maternal age
20–24 5 0.5 0 0.0
<0.001
25–29 85 9.1 30 13.1
30–34 328 35.1 105 45.9
35–39 394 42.2 82 35.8
≥40 122 13.1 12 5.2
Range 23–46 25–42




<12 4 0.4 0 0.0
12–21 62 6.6 13 5.7
22–27 20 2.1 13 5.7
28–36 122 13.1 119 52.0
37–41 613 65.6 78 34.1
≥42 8 0.9 0 0.0
Unknown/missing values 105 11.2 6 2.6
Range 10–42 12–41
Mean ± SD 36.1 ± 6.3 34.0±5.2
Median 38.0 36.0
Sex
Male 453 48.5 111 48.5
n.s. Female 350 37.5 91 39.7
Unknown/missing values 131 14.0 27 11.8
Neonatal outcome
Abortion (<22 weeks) 133 14.2 14 6.1
<0.001 Stillbirths (22 ≤ weeks) 37 4.0 5 2.2
Live-births 764 81.8 210 91.7
Early neonatal death (neonatal death up to day 6 after birth)
Yes 27 3.5 22 10.5
<0.001 No 539 70.6 153 72.9
Unknown/missing values 198 25.9 35 16.7
aPercentage of singletons and multiples within each year were calculated.
n.s.: not signiﬁcant.
Unknown/missing values were excluded in the statistic tests.
plurality in Table 1. The percentage of multiple births in
each year tended to decrease signiﬁcantly from 2004 to
2008. Maternal age was signiﬁcantly higher in singletons.
Gestational weeks were signiﬁcantly longer in singletons.
There was no signiﬁcant sex diﬀerence. Males were more
frequent in both singletons and multiples. Live-births were
more frequent in multiples, while early neonatal death was
also more frequent in multiples. Unknown/missing values of
early neonatal death in singletons were very high (26%).
The crude percentage of birth defects in ART pregnancy
according to plurality are shown in Table 2. The percentage
increased with birth year. The percentages in multiples were4 Journal of Pregnancy
Table 2: Crude percentage of birth defects in ART pregnancy according to plurality.
Year Singletons Multiples RR (95% CI) Total
2004 0.43 (88/20,304) 0.97 (35/3,612) 2.24 (1.51–3.30) 0.50 (123/23,916)
2005 0.53 (119/22,524) 0.92 (35/3,784) 1.75 (1.20–2.55) 0.59 (154/26,308)
2006 0.67 (165/24,787) 1.52 (52/3,424) 2.28 (1.67–3.11) 0.77 (218/28,211)
2007 0.93 (240/25,944) 1.92 (62/3,221) 2.08 (1.58–2.74) 1.04 (304/29,165)
2008 1.06 (322/30,372) 2.10 (45/2,139) 1.98 (1.46–2.70) 1.13 (368/32,511)
Total 0.75 (934/123,931) 1.42 (229/16,180) 1.88 (1.60–2.13) 0.83 (1,167/140,111)a
Numbers of ART pregnancies according to plurality were presented in the JSOG annual report.
aTotal number includes four subjects with unknown plurality.
Table 3: Crude percentage of birth defects in ART live-born babies according to plurality.
Year Singletons Multiples RR (95% CI) Total
2004 0.54 (69/12,851)a 0.51 (27/5,317)a 0.95 (0.61–1.47)a
0.52 (96/18,168)
0.55 (69/12,562)b 0.48 (27/5,606)b 0.88 (0.56–1.37)b
2005 0.67 (91/13,601)a 0.60 (33/5,511)a 0.90 (0.60–1.33)a
0.65 (124/19,112)
0.68 (91/13,324)b 0.57 (33/5,788)b 0.83 (0.56–1.24)b
2006 0.94 (140/14,876)a 1.04 (49/4,711)a 1.11 (0.80–1.53)a
0.96 (190/19,587)
0.96 (140/14,649)b 0.99 (49/4,938)b 1.04 (0.75–1.44)b
2007 1.28 (200/15,681) 1.43 (56/3,914) 1.12 (0.84–1.51) 1.32 (258/19,595)
2008 1.39 (264/19,034) 1.69 (45/2,670) 1.22 (0.89–1.66) 1.43 (310/21,704)
Total 1.00 (764/76,043)a 0.95 (210/22,123)a 0.94 (0.81–1.10)a
0.99 (978/98,166)c
1.02 (764/75,250)b 0.92 (210/22,916)b 0.90 (0.78–1.05)b
Numbers of ART live births according to plurality from 2004 to 2006 were estimated by the present author using JSOG annual report.
Numbers of ART live births according to plurality from 2007 to 2008 were presented in the JSOG annual report.
aMinimum estimation of numbers of multiples.
bMaximum estimation of numbers of multiples.
cTotal number includes four subjects with unknown plurality.
consistently higher than in singletons. RR is around 2 and
is statistically signiﬁcant throughout all 5 years (RR = 1.88,
95% CI 1.60–2.13 in total).
The crude percentage of birth defects in ART live-born
babies are shown in Table 3. The percentage and RR slightly
and consistently increased with birth year. The percentages
of multiples were higher than those of singletons after 2006.
RR was around 1 and statistically not signiﬁcant throughout
all 5 years (RR = 0.90, 95% CI 0.78–1.05 or RR = 0.94, 95%
CI 0.81–1.10 in total).
The crude percentage of birth defects per total ART
deliveries (including singleton stillbirth deliveries, singleton
live-birth deliveries, stillbirth deliveries of multiples, and
live-birth deliveries of multiples) were 0.64% (100/15,524)
in 2004, 0.81% (133/16,385) in 2005, 1.13% (196/17,280) in
2006, 1.51% (268/17,761) in 2007, and 1.56% (320/20,542)
in 2008. Throughout the 5 years in total, 1.16% of all
neonates born after ART had birth defects (1,017/87,492,
with 86,914 live deliveries, 578 stillbirth deliveries).
Although it became clear that there were a very high
number of unknown/missing values of early neonatal death,
the early neonatal mortality rate between singletons and
multiples was compared for reference. The crude percentages
of early neonatal death with birth defects are shown in
Table 4. Although the percentages in multiples were consis-
tentlyhigherthaninsingletons,RRvariedwidelybyyearand
was not necessarily signiﬁcant. However, RR was statistically
signiﬁcant throughout the ﬁve years (RR = 2.68, 95% CI
1.52–4.70 or RR = 2.80, 95% CI 1.60–4.92 in total).
The crude early neonatal mortality with birth defects in
ART and the general population (vital statistics) is shown in
Table 5. Early neonatal mortality was slightly higher in ART
(5.09 per 10,000 live births) than in the general population
(3.86per10,000livebirths)withmarginalsigniﬁcance(RR =
1.32, 95% CI 1.00–1.75 in total).
The results of the logistic regression analyses are as
follows. Neonatal outcome of birth defects after ART
(whether stillbirths or live births) was strongly inﬂuenced
by gestational week (P<. 0001) and moderately by plurality
(P = .02). Stillbirths were more frequently seen in singletons
than in multiples. Early neonatal mortality of birth defects
after ART (whether early neonatal death or not) was strongly
inﬂuenced by gestational week (P<. 0001).
4. Discussion
The present study for the ﬁrst time showed the nationwide
prevalence of birth defects after ART according to plurality
in Japan, although there are several limitations to the study
mentioned below.
The percentage of birth defects per pregnancies and live
births increased steadily by year, from 2004 to 2008, for bothJournal of Pregnancy 5
Table 4: Crude early neonatal mortality rate of birth defects (per 1,000 ART live births).
Year Singletons Multiples RR (95% CI) Total
2004 0.16 (2/12,851)a 0.56 (3/5,317)a 3.63 (0.61–21.69)a
0.28 (5/18,168)
0.16 (2/12,562)b 0.54 (3/5,606)b 3.36 (0.56–20.11)b
2005 0.37 (5/13,601)a 0.54 (3/5,511)a 1.48 (0.35–6.19)a
0.42 (8/19,112)
0.38 (5/13,324)b 0.52 (3/5,788)b 1.38 (0.33–5.78)b
2006 0.47 (7/14,876)a 1.91 (9/4,711)a 4.06 (1.51–10.90)a
0.82 (16/19,587)
0.48 (7/14,649)b 1.82 (9/4,938)b 3.81 (1.42–10.24)b
2007 0.32 (5/15,681) 0.51 (2/3,914) 1.60 (0.31–8.26) 0.41 (8/19,595)
2008 0.42 (8/19,034) 1.87 (5/2,670) 4.46 (1.46–13.61) 0.60 (13/21,704)
Total 0.36 (27/76,043)a 0.99 (22/22,123)a 2.80 (1.60–4.92)a
0.51 (50/98,166)c
0.36 (27/75,250)b 0.96 (22/22,916)b 2.68 (1.52–4.70)b
Numbers of ART live births according to plurality from 2004 to 2006 were estimated by the present author using JSOG annual report.
Numbers of ART live births according to plurality from 2007 to 2008 were presented in the JSOG annual report.
aMinimum estimation of numbers of multiples.
bMaximum estimation of numbers of multiples.
cTotal number includes one subject with unknown plurality.
Table 5: Crude early neonatal mortality rate as to birth defects (per 10,000 live births).
Year ART Total births RR (95% CI)
2004 2.75 (5/18,168) 4.27 (474/1,110,721) 0.64 (0.27–1.56)
2005 4.19 (8/19,112) 3.78 (402/1,062,530) 1.11 (0.55–2.23)
2006 8.17 (16/19,587) 3.86 (422/1,092,674) 2.11 (1.28–3.48)
2007 4.08 (8/19,595) 3.95 (431/1,089,818) 1.03 (0.51–2.08)
2008 5.99 (13/21,704) 3.41 (372/1,091,156) 1.76 (1.01–3.05)
Total 5.09 (50/98,166) 3.86 (2,101/5,446,899) 1.32 (1.00–1.75)
Numbers of total ART live births were presented in the JSOG annual report.
Crude neonatal mortality rate of total births were calculated using vital statistics.
singletons and multiples. Although the deﬁnitive reason for
this is unclear, one possible reason is that the precision of
diagnosis improved.
In Japan, the percentage of birth defects per births were
reported to be 1.77–1.95% from 2004 to 2006 according to
the report of the ICBDMS Japan Center (http://www.icbdsrj
.jp/2004data.html, in Japanese, accessed August 2011). This
value is slightly higher than that of ART in the present
study. However, direct comparison is impossible, because the
present rate shown in Table 3 was for live births. Even if the
percentage of birth defects per ART births were calculated
assuming that stillbirths rate (22 or more weeks) according
to plurality in ART and general population is equal and
estimate the number of stillbirths using this rate according
to plurality, the results were not dramatically changed (1.05-
1.06%insingletonsand0.91–0.94%inmultiples,calculation
process not shown). Moreover, the method of data collection
and diagnosis may be diﬀerent. Fujii et al. [26]r e p o r t e di n
the recent study that the percentage of birth defects rate in
singleton births are 2.3% in IVF and 2.0% in a spontaneous
singletons control, using the 2006 JSOG database. According
to Fujii et al. [26], this data is not nationwide, which
represents a large proportion of referral hospital data, with
a large proportion of high-risk pregnancy population.
The present percentage of birth defects after ART are
overall lower compared with other studies seen in many
reviews [4, 6, 11]. Nevertheless, the main objective of this
study was to evaluate the birth defect rate in multiple births
compared to singletons within Japan and not to compare the
birthdefectratesacrosscountries.Therefore,thecomparison
of birth defects in multiple births and singletons may be
biased only if there is diﬀerential reporting according to
plurality, which is not likely to occur [16].
The percentage of birth defects are clearly higher in
multiple pregnancies than in singleton pregnancies with RR
around 2 (Table 2), whereas the percentage of birth defects
after ART in live ART births are equal in the two groups
(Table 3). But caution is demanded, because pregnancies
were counted by the number of pregnant women not by the
number of fetuses. These results should be examined while
consideringfamilysize(numberofchildreninonefamily).If
a certain family has two children after ART, the risk for birth
defects is nearly the same, from the family’s point of view,
whether they are two singletons or one pair of twins. There
exist no direct data indicating the mean number of ART
children per family in Japan. According to the vital statistics
in Japan, the mean number of children under 6 years old in
one family, not stratiﬁed by the method of conception, was
ca. 1.3 between 2004 and 2008. If the number of children in6 Journal of Pregnancy
one family is the same whether the children are born after
ART or spontaneously, this suggests that the risk of having
birth defects in at least one baby in one family after ART may
become higher in families with multiples with at least two
children than in families with singletons. Therefore, the risk
of birth defects after ART in multiples should be considered
in not only the standpoint of births (babies), but maternity
or family, as far as social impact of ART is concerned.
The higher percentage of abortion and/or stillbirth in
singletons were observed, as shown in Table 1. The results of
the logistic regression analysis for neonatal outcome of birth
defects (whether stillbirths or live births) coincided with this
result, although the reasons were unclear.
According to Bonduelle et al. [27], major birth defects
after ICSI were found in 3.07% (46/1,499) of the singleton
children and in 3.73% (50/1,341) of the children from
multiple pregnancies. Major birth defects were found after
IVF in 3.15% (49/1,556) of the singleton children and in
4.50% (63/1,399) of the children from multiple pregnancies.
The rates of birth defects in multiples were signiﬁcantly
higher than in singletons in ICSI as well as in IVF (P<. 05).
Pinborg et al. [28] compared twins and singletons after
ART (IVF/ICSI) using a Danish national birth cohort and
their record linkage. They reported that the rate of major
birth defects was not statistically signiﬁcant between twins
and singletons, whereas the total malformation rate (major
and minor) was higher in twins than in singletons (P =
.001). Other items, such as the risk for stillbirths, preterm
delivery, low birthweight, use of cesarean sections, and
admittance to a neonatal intensive care unit, were all higher
in twins than in singletons, and the researchers concluded
that neonatal outcome in IVF/ICSI twins is considerably
poorer than in singletons.
As is well known, the Japanese perinatal and neonatal
healthcare system and other factors such as universal access
to healthcare, established referral mechanisms, and compli-
ance of patients with pregnancy followup are all factors that
make Japan one of the most developed countries in the ﬁeld
ofmaternalandchildhealth[26].Forexample,vitalstatistics
show that the infant mortality (within one year after birth)
rate is one of the lowest in the world (2.4 per 1,000 live births
in 2009). Of them, birth defects have been the most serious
cause of early neonatal mortality, neonatal mortality (within
28 days after birth), and infant mortality. The early neonatal
mortality rate from 2004 to 2008 attributed to birth defects
was consistently around 40%. Given the consistent increase
oflivebirthsafterART,theimpactofART-relateddeathsdue
to birth defects is a public health concern.
As shown in Table 1, followup of neonates after ART
is insuﬃcient, with almost 26% unknown/missing values
for early neonatal mortality. The present values are the
minimum numbers, since more early neonatal deaths with
birth defects deﬁnitely occur in complete dataset without
unknown/missing values. The early neonatal mortality rate
was slightly higher in ART than in the general population
(RR = 1.32, 95% CI 1.00–1.75), as shown in Table 5,e v e n
using the minimum numbers of neonatal deaths with birth
defects. The possibility that the mortality rate of neonates
with birth defects after ART is higher than that in the general
population,ornon-ARTpopulation,cannotbedenied.Since
the present neonatal mortality rate after ART is a minimum
estimate, precise information concerning deﬁnite followups
after ART is essential.
This study has the following limitations, most of which
could be attributed to the dataset, namely, the fact that
individual information was obtained only from the subjects
with birth defects after ART, not the total ART pregnancies.
The ﬁrst and greatest limitation is that the author could
not control for confounding factors that can aﬀect ART
and/or birth defects, such as maternal age, parity, smoking
[6, 29], and socioeconomic status, since these data on
the general ART populations were not available. However,
many research studies to date do not necessarily control for
confounding factors [5]. Second, direct comparison between
the present ART data and birth defects data, and vital
statistics (early neonatal mortality rate) may be impossible,
because the diagnostic or inclusion criteria for birth defects
are not necessarily the same across the dataset. Third, all
methods of ART, that is, IVF, ICSI, and so on, were treated
as ART. Regarding this point, a recent meta-analysis [30]
and national study [27] reported that the ICSI procedure
represents no signiﬁcant additional risks of major birth
defects in addition to the risks involved in standard IVF.
The author treated total birth defects, not each disease,
in the present study to estimate the total impact of ART
on birth defects. It is possible that each disease is related to
methodsofconception(IVForICSI),plurality(singletonsor
multiples), or other factors. For example, some birth defects
in the urogenital system of boys are reported to be higher in
ICSIthaninIVF[29,31].Patentductusarteriosusisstrongly
associated with preterm birth and may be higher in twins
than in singletons [28, 32]. Further analysis of each disease
is essential.
The increased risk of adverse outcome in ART mul-
tiples/twins is not limited to adverse neonatal outcome.
ART twins are more likely to develop cerebral palsy and
be hospitalized than ART singletons [33, 34]. According
to the questionnaire survey by Pinborg et al. [35], speech
development and physical health up to 4 years of age were
signiﬁcantly worse in twins than in singletons, and twins
were more likely to have special needs and require surgical
interventions than singletons. Maternal risks increased in
ART twin pregnancies, as the women were more likely to be
on sick leave and hospitalized during pregnancy [36].
The mothers of iatrogenic multiple-birth children are
clearly older than the mothers of singletons in Japan [37].
Their advanced age makes the physical, mental, and social
burden of rearing two babies at once even greater. This
situation could increase the risk of maternal problems such
aspostpartumdepression,diﬃcultieswithchildrearing,and,
in the worst case, child abuse [37–40].
These adverse outcomes of twin pregnancy after ART
promoted an elective single embryo transfer policy for ART
[41, 42]. While ART multiples decreased dramatically after
2006 in Japan [37], long-term social as well as medical
followup for mothers of multiples and the multiples them-
selves was rarely performed. A standardized methodology
of followup studies after ART should be established [43].Journal of Pregnancy 7
Considering the medical and social impacts of multiple
births [37–40], there is an urgent need for a hospital-based
monitoring system for fertility treatments, including not
only ART but also non-ART treatment, and multiple births
in Japan [25, 37]. Moreover, eﬀective record linkage between
data on fertility treatment, birth defects, and vital statistics is
essential.
The risk of birth defects in ART live births is not
signiﬁcantly diﬀerent between multiples and singletons, but
the impact of birth defects after ART would be larger in
families with multiples, since the mean number of children
would be larger in these families compared to families
with singletons. Proper followup for all families, especially
for families with multiple pregnancies/births, after ART is
needed.
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